Table 2.
2a. | |||||
---|---|---|---|---|---|
CT positive | CT negative | Sensitivity | 100% (88–100) | ||
UCH-L1 positive ≥0.09 ng/ml | 28 | 61 | Specificity | 21% (13–32) | |
UCH-L1 negative <0.09 ng/ml | 0 | 16 | NPV | 100% (76–100) | |
PPV | 31% (22–42) | ||||
2b. | |||||
Neurosurgical Intervention | No Neurosurgical Intervention | Sensitivity | 100% (73–100) | ||
UCH-L1 positive ≥0.21 ng/ml | 14 | 39 | Specificity | 57% (46–67) | |
UCH-L1 negative <0.21 ng/ml | 0 | 52 | NPV | 100% (91–100) | |
PPV | 26% (16–41) |